|
1) Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005; 308: 1635-8
|
|
|
|
2) 辧野義己. 腸内常在菌叢の多様性解析とその必要性. Medical Science Digest. 2006; 32: 373-9
|
|
|
|
|
3) Floch MH, Madsen KK, Jenkins DJ, et al. Recommendations for probiotic use. J Clin Gastroenterol. 2006; 40: 275-8
|
|
|
|
|
|
4) Montrose DC, Floch MH, Montrose DC, et al. Probiotics used in human studies. J Clin Gastroenterol. 2005; 39: 469-84
|
|
|
|
|
|
5) Macfarlane S, Macfarlane GT, Cummings JH, et al. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther. 2006; 24: 701-14
|
|
|
|
|
|
6) 服部正平, 榊 佳之. 細菌叢メタゲノム解析の意義とヒトゲノム計画. 臨床と微生物. 2006; 33: 115-20
|
|
|
|
|
|
7) 高橋志達, 田口晴彦, 神谷 茂. プロバイオティクス, プレバイオティクスおよびシンバイオティクス. 臨床と微生物. 2006; 33: 147-51
|
|
|
|
|
|
8) Guandalini S, Guandalini S. Probiotics for children: use in diarrhea. J Clin Gastroenterol. 2006; 40: 244-8
|
|
|
|
|
|
9) McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007; 5: 97-105
|
|
|
|
|
|
10) Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. Cochrane Database of Systematic Reviews. 2004; (2): CD003048
|
|
|
|
|
|
11) Szajewska H, Skorka A, Dylag M, et al. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007; 25: 257-64
|
|
|
|
|
|
12) Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J Clin Gastroenterol. 2006; 40: 249-55
|
|
|
|
|
|
13) Correa NB, Peret Filho LA, Penna FJ, et al. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005; 39: 385-9
|
|
|
|
|
|
14) Kotowska M, Albrecht P, Szajewska H, et al. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005; 21: 583-90
|
|
|
|
|
|
15) Hawrelak JA, Whitten DL, Myers SP, et al. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review. Digestion. 2005; 72: 51-6
|
|
|
|
|
|
16) McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006; 101: 812-22
|
|
|
|
|
|
17) Johnston BC, Supina AL, Ospina M, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews. 2007; (2): CD004827
|
|
|
|
|
|
18) Lewis S, Burmeister S, Brazier J, et al. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005; 3: 442-8
|
|
|
|
|
|
19) Lewis S, Burmeister S, Cohen S, et al. Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2005; 21: 469-77
|
|
|
|
|
|
20) 味村俊樹, 野澤慶次郎, 松田圭二, 他. 炎症性腸疾患. 臨床と微生物. 2006; 33: 163-9
|
|
|
|
|
|
21) Ewaschuk JB, Dieleman LA, Ewaschuk JB, et al. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol. 2006; 12: 5941-50
|
|
|
|
|
|
22) Gionchetti P, Rizzello F, Lammers KM, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol. 2006; 12: 3306-13
|
|
|
|
|
|
23) Kato K, Mizuno S, Umesaki Y, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther. 2004; 20: 1133-41
|
|
|
|
|
|
24) Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 2005; 100: 1539-46
|
|
|
|
|
|
25) Chapman TM, Plosker GL, Figgitt DP, et al. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs. 2006; 66: 1371-87
|
|
|
|
|
|
26) Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004; 53: 108-14
|
|
|
|
|
|
27) 味村俊樹, 山田英樹, 大見琢磨, 他. 難治性回腸嚢炎に対するプロバイオティクス(ビフィコロン)による緩解維持療法. 日本臨床腸内微生物学会誌. 2006; 7: 27-33
|
|
|
|
|
|
28) Rolfe VE, Fortun PJ, Hawkey CJ, et al. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2006; (4): CD004826
|
|
|
|
|
|
29) Camilleri M, Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006; 40: 264-9
|
|
|
|
|
|
30) 福土 審. 腸内細菌と過敏性腸症候群(IBS). Medical Science Digest. 2006; 32: 388-91
|
|
|
|
|
|
31) O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005; 128: 541-51
|
|
|
|
|
|
32) Kim HJ, Vazquez Roque MI, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005; 17: 687-96
|
|
|
|
|
|
33) Tong JL, Ran ZH, Shen J, et al. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2007; 25: 155-68
|
|
|
|
|
|
34) 古賀泰浩. ヘリコバクター・ピロリ感染症. 臨床と微生物. 2006; 33: 158-62
|
|
|
|
|
|
35) 和田万里子, 山城雄一郎. アレルギー疾患. 臨床と微生物. 2006; 33: 170-4
|
|
|
|
|
|
36) Passeron T, Lacour JP, Fontas E, et al. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy. 2006; 61: 431-7
|
|
|
|
|
|
37) Othman M, Neilson JP, Alfirevic Z, et al. Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews. 2007; (1): CD005941
|
|
|
|
|
|
38) Nishijima K, Shukunami K, Kotsuji F, et al. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. J Clin Gastroenterol. 2005; 39: 447-8
|
|
|
|
|
|
39) Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005; 390: 104-13
|
|
|
|
|
|
40) Watkinson PJ, Barber VS, Dark P, et al. The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007; 26: 182-92
|
|
|
|
|
|
41) Ishikawa H, Akedo I, Otani T, et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005; 116: 762-7
|
|
|
|
|